BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6290259)

  • 1. Synthetic corticoliberin needs arginine vasopressin for full corticotropin releasing activity.
    Bény JL; Baertschi AJ
    Experientia; 1982 Sep; 38(9):1078-9. PubMed ID: 6290259
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor (CRF) in rat anterior pituitary cells in culture.
    Giguere V; Labrie F
    Endocrinology; 1982 Nov; 111(5):1752-4. PubMed ID: 6290198
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin and adrenocorticotropin (ACTH) release: direct effects at the anterior pituitary level and potentiation of arginine vasopressin-induced ACTH release.
    Spinedi E; Negro-Vilar A
    Endocrinology; 1983 Apr; 112(4):1217-23. PubMed ID: 6299688
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of ACTH secretion from corticotrophs: the interaction of vasopressin and CRF.
    Bilezikjian LM; Vale WW
    Ann N Y Acad Sci; 1987; 512():85-96. PubMed ID: 2831787
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxytocin as well as vasopressin potentiate ovine CRF in vitro.
    Antoni FA; Holmes MC; Jones MT
    Peptides; 1983; 4(4):411-5. PubMed ID: 6316291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin.
    Turkelson CM; Thomas CR; Arimura A; Chang D; Chang JK; Shimizu M
    Peptides; 1982; 3(2):111-3. PubMed ID: 6285317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for intrapituitary intercellular control of adrenocorticotropin secretion.
    Schwartz J
    Mol Cell Endocrinol; 1990 Jan; 68(2-3):77-83. PubMed ID: 2155839
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of hypothalamic corticotropin releasing activity by vasopressin: studies in the Brattleboro rat.
    Buckingham JC
    Ann N Y Acad Sci; 1982; 394():580-6. PubMed ID: 6295234
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
    Vlaskovska M; Hertting G; Knepel W
    Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticoliberin (CRF) activity of the rat neurohypophysis.
    Kárteszi M; Stark E; Makara GB; Fazekas I; Rappay G
    Endocrinol Exp; 1978 Dec; 12(4):204-8. PubMed ID: 220011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary.
    Levin N; Blum M; Roberts JL
    Endocrinology; 1989 Dec; 125(6):2957-66. PubMed ID: 2555132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of corticotropin-releasing hormone and arginine vasopressin responsiveness during late-gestation pregnancy in sheep.
    Young SF; Rose JC
    Biol Reprod; 2002 Jun; 66(6):1805-12. PubMed ID: 12021066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor can stimulate gonadotropin secretion by human fetal pituitaries in superfusion.
    Blumenfeld Z; Kuhn RW; Jaffe RB
    Am J Obstet Gynecol; 1986 Mar; 154(3):606-12. PubMed ID: 3006494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs.
    Knepel W; Homolka L; Vlaskovska M; Nutto D
    Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor stimulates accumulation of adenosine 3', 5'-monophosphate in rat pituitary corticotrophs.
    Labrie F; Veilleux R; Lefevre G; Coy DH; Sueiras-Diaz J; Schally AV
    Science; 1982 May; 216(4549):1007-8. PubMed ID: 6281886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
    Familari M; Smith AI; Smith R; Funder JW
    Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary receptors for corticotropin-releasing factor: no effect of vasopressin on binding or activation of adenylate cyclase.
    Holmes MC; Antoni FA; Szentendrei T
    Neuroendocrinology; 1984 Aug; 39(2):162-9. PubMed ID: 6089019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocortin 1 and hypothalamo-pituitary function in the rat.
    Taylor AD; Loxley HD; Flower RJ; Buckingham JC
    Ann N Y Acad Sci; 1994 Nov; 746():441-5. PubMed ID: 7529974
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro adrenocorticotropin/beta-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity.
    Knepel W; Homolka L; Vlaskovska M; Nutto D
    Endocrinology; 1984 May; 114(5):1797-804. PubMed ID: 6325132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.